Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Open Access

Platelet dysfunction in immune thrombocytopenia: finding clinical subsets with platelet phenotypes

View Full Paper
Ask AI
Bookmark
Share

Authors

SASidra AliAustralian National UniversitySHSarah M. HicksAustralian National UniversityLCLucy A. CouplandLiverpool Hospital

Discussion

Loading...

Member takes

Implication

Observational analysis reveals platelet dysfunction in ITP patients, suggesting biomarkers could improve bleeding predictions.

Key Points

  • Elevated glycoprotein VI and thrombopoietin were significantly associated with bleeding in primary ITP patients.
  • Platelet indices improved the bleeding predictive model accuracy from 70.48% to 78.1% in patients with ITP.
  • Flow cytometry was used to assess platelet surface proteins and activation markers in ITP patients compared to healthy donors.
  • Identifying biomarkers for ITP can lead to better-defined clinical subsets, enhancing management and treatment.

Cite This Study

Ali et al. (2025) studied this question.

synapsesocial.com/papers/68c1c22554b1d3bfb60ef232https://doi.org/10.1101/2025.07.15.25331619
View Full Paper
Ask AI
Bookmark
Share